Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome

被引:164
|
作者
Konishi, Tsuyoshi [1 ,2 ]
Shimada, Yoshifumi [1 ,3 ]
Hsu, Meier [4 ]
Tufts, Lauren [1 ]
Jimenez-Rodriguez, Rosa [1 ]
Cercek, Andrea [5 ]
Yaeger, Rona [5 ]
Saltz, Leonard [5 ]
Smith, J. Joshua [1 ]
Nash, Garrett M. [1 ]
Guillem, Jose G. [1 ]
Paty, Philip B. [1 ]
Garcia-Aguilar, Julio [1 ]
Gonen, Mithat [4 ]
Weiser, Martin R. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[3] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata, Japan
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
COLORECTAL-CANCER; TUMOR-MARKERS; PROGNOSTIC-SIGNIFICANCE; CURATIVE RESECTION; FOLLOW-UP; CEA; LEVEL; STAGE; RECURRENCE; METASTASES;
D O I
10.1001/jamaoncol.2017.4420
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMPORTANCE Guidelines recommend measuring preoperative carcinoembryonic antigen (CEA) in patients with colon cancer. Although persistently elevated CEA after surgery has been associated with increased risk formetastatic disease, prognostic significance of elevated preoperative CEA that normalized after resection is unknown. OBJECTIVE To investigate whether patients with elevated preoperative CEA that normalizes after colon cancer resection have a higher risk of recurrence than patients with normal preoperative CEA. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort analysiswas conducted at a comprehensive cancer center. Consecutive patients with colon cancer who underwent curative resection for stage I to III colon adenocarcinoma at the center from January 2007 to December 2014 were identified. EXPOSURES Patients were grouped into 3 cohorts: normal preoperative CEA, elevated preoperative but normalized postoperative CEA, and elevated preoperative and postoperative CEA. MAIN OUTCOMES AND MEASURES Three-year recurrence-free survival (RFS) and hazard function curves over time were analyzed. RESULTS A total of 1027 patients (461 [50.4%] male; median [IQR] age, 64 [53-75] years) were identified. Patients with normal preoperative CEA had 7.4% higher 3-year RFS (n = 715 [89.7%]) than the combined cohorts with elevated preoperative CEA (n = 312 [82.3%]) (P =.01) but had RFS similar to that of patients with normalized postoperative CEA (n = 142 [87.9%]) (P =.86). Patients with elevated postoperative CEA had 14.9% lower RFS (n = 57 [74.5%]) than the combined cohorts with normal postoperative CEA (n = 857 [89.4%]) (P =.001). The hazard function of recurrence for elevated postoperative CEA peaked earlier than for the other cohorts. Multivariate analyses confirmed that elevated postoperative CEA (hazard ratio [HR], 2.0; 95% CI, 1.1-3.5), but not normalized postoperative CEA (HR, 0.77; 95% CI, 0.45-1.30), was independently associated with shorter RFS. CONCLUSIONS AND RELEVANCE Elevated preoperative CEA that normalizes after resection is not an indicator of poor prognosis. Routine measurement of postoperative, rather than preoperative, CEA is warranted. Patients with elevated postoperative CEA are at increased risk for recurrence, especially within the first 12 months after surgery.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [21] Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer
    Kim, Han-Gil
    Yang, Seung Yoon
    Han, Yoon Dae
    Cho, Min Soo
    Min, Byung Soh
    Lee, Kang Young
    Kim, Nam Kyu
    Hur, Hyuk
    PLOS ONE, 2021, 16 (06):
  • [22] Preoperative Carcinoembryonic Antigen Level as an Independent Prognostic Factor in Potentially Curative Colon Cancer
    Huh, Jung Wook
    Oh, Byung Ryul
    Kim, Hyeong Rok
    Kim, Young Jin
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (05) : 396 - 400
  • [23] Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer
    Heita Ozawa
    Kenjiro Kotake
    Miki Hosaka
    Akira Hirata
    Yusuke Nakagawa
    Shin Fujita
    Kenichi Sugihara
    International Journal of Colorectal Disease, 2017, 32 : 821 - 829
  • [24] SERUM CEA (CARCINOEMBRYONIC ANTIGEN) MONITORING AFTER SURGERY FOR CANCER OF THE RECTUM AND COLON
    REGINSTER, JY
    DESAIVE, C
    COLLETTE, J
    ZANGERLE, PF
    DENIS, D
    FRANCHIMONT, P
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1984, 20 (04): : 203 - 206
  • [25] Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer
    Ozawa, Heita
    Kotake, Kenjiro
    Hosaka, Miki
    Hirata, Akira
    Nakagawa, Yusuke
    Fujita, Shin
    Sugihara, Kenichi
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (06) : 821 - 829
  • [26] Preoperative Carcinoembryonic Antigen Elevation in Colorectal Cancer
    Yeh, Chien-Yuh
    Hsieh, Pao-Shiu
    Chiang, Jy-Ming
    Lai, Cheng-Chou
    Chen, Jinn-Shiun
    Wang, Jeng-Yi
    Hung, Hsin-Yuan
    HEPATO-GASTROENTEROLOGY, 2011, 58 (109) : 1171 - 1176
  • [27] Postoperative, Rather than Preoperative CEA Predicts Outcome in Colon Cancer
    Konishi, T.
    Shimada, Y.
    Morris, M.
    Smith, J.
    Nash, G.
    Temple, L.
    Guillem, J. G.
    Paty, P. B.
    Garcia-Aguilar, J.
    Weiser, M. R.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S90 - S91
  • [28] Is decrement ratio between preoperative and postoperative serum carcinoembryonic antigen level considered as a predictive prognostic indicator in colorectal cancer patients?
    Kim, NR
    Cho, MY
    Kim, SH
    Suh, SO
    Moon, HY
    Whang, CW
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 224 - 224
  • [29] CARCINOEMBRYONIC ANTIGEN AND PROGNOSIS IN PATIENTS WITH COLON CANCER
    LOGERFO, P
    HERTER, FP
    ANNALS OF SURGERY, 1975, 181 (01) : 81 - 84
  • [30] Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer
    Polat, E.
    Duman, U.
    Duman, M.
    Atici, A. E.
    Reyhan, E.
    Dalgic, T.
    Bostanci, E. B.
    Yol, S.
    CURRENT ONCOLOGY, 2014, 21 (01) : E1 - E7